Aktie 4130 GENOVATE BIOTECHNOLOGY CO., LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Genovate Biotechnology Co., Ltd.

Aktien

4130

TW0004130000

4130

Schlusskurs Taipei Exchange
Andere Börsenplätze
 00:00:00 30.04.2024 		% 5 Tage % 1. Jan.
24.45 TWD +0.41% Intraday Chart für Genovate Biotechnology Co., Ltd. +2.30% -8.08%
28.03. Genovate Biotechnology Co., Ltd. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI
2023 Genovate Biotechnology Co., Ltd. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Genovate Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Genovate Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Genovate Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Genovate Biotechnology Co., Ltd. Announces Members of the Company's 5th Remuneration Committee
Genovate Biotechnology Co., Ltd. Announces Cash Dividend, Payable August 7, 2023
Genovate Biotechnology Co., Ltd. Approves Election of Directors
Genovate Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Genovate Biotechnology Co., Ltd. and CSPC Pharmaceutical Group Limited Sign the Agreement on Technology Licensing and Co-Development of DBPR108 in Mainland China
Genovate Biotechnology Co., Ltd. Announces Resignation of Chen, Tehfang as Audit Committee Member and Convener of the Remuneration Committee, Effective April 10, 2023
Genovate Biotechnology Co., Ltd. Announces Resignation of Chen, Tehfang as Independent Director, Effective April 10, 2023
Genovate Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Genovate Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Genovate Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Genovate Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Genovate Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Genovate Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Genovate Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
Genovate Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
Genovate Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021
Genovate Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 4130 Aktie
  4. Nachrichten Genovate Biotechnology Co., Ltd.
  5. Andere Sprachen